Cheryl K Zogg1,2, Taylor D Ottesen3, Kareem J Kebaish3, Anoop Galivanche3, Shilpa Murthy4,5, Navin R Changoor4, Donald L Zogg6, Timothy M Pawlik7, Adil H Haider4. 1. Yale School of Medicine, 67 Cedar Street, Room 316 ESH, New Haven, CT, 06520, USA. czogg@jhmi.edu. 2. Center for Surgery and Public Health, Harvard Medical School and Harvard T.H. Chan School of Public Health, Department of Surgery, Brigham and Women's Hospital, Boston, MA, USA. czogg@jhmi.edu. 3. Yale School of Medicine, 67 Cedar Street, Room 316 ESH, New Haven, CT, 06520, USA. 4. Center for Surgery and Public Health, Harvard Medical School and Harvard T.H. Chan School of Public Health, Department of Surgery, Brigham and Women's Hospital, Boston, MA, USA. 5. Department of Surgery, Indiana University School of Medicine, Indianapolis, IN, USA. 6. Minnesota Gastroenterology, P.A., Saint Paul, MN, USA. 7. Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
Abstract
BACKGROUND: Rising healthcare costs have led to increased focus on the need to achieve a higher "value of care." As value-maximization efforts expand to include more complex surgical patients, evidence to support meaningful implementation of complication-based initiatives is lacking. The objective of this study was to compare incremental costs of complications following major gastrointestinal (GI) resections for organ-specific malignant neoplasia using nationally representative data. METHODS: National (Nationwide) Inpatient Sample data, 2001-2014, were queried for adult (≥ 18 years) patients undergoing major resections for malignant neoplasia. Based on system-based complications considered relevant to the long-term treatment of GI disease, stratified differences in risk-adjusted incremental hospital costs and complication probabilities were compared. Differences in surgical outcomes and costs over time were also assessed. RESULTS: A total of 293,967 patients were included, weighted to represent 1,408,117 patients nationwide. One fourth (26.1%; 95% CI, 25.7-26.4%) experienced ≥ 1 pre-discharge complication (range, 45.3% esophagectomy to 24.0% rectal resection). Resultant annual risk-adjusted incremental hospital costs totaled $540 million nationwide (19.5% of the overall cost of care and an average of $20,900 per patient). Costs varied substantially with both cancer/resection type and complication group, ranging from $76.7 million for colectomies with infectious complications to $0.2 million for rectal resections with urinary complications. For each resection type, infectious ($154.7 million), GI ($85.5 million), and pulmonary ($77.9 million) complications were among the most significant drivers of increased hospital cost. CONCLUSIONS: Quantifying and comparing the impact of complications on an indication-specific level in more complex patients offers an important step toward allowing providers/payers to meaningfully prioritize the design of novel and adaptation of existing value-maximization approaches.
BACKGROUND: Rising healthcare costs have led to increased focus on the need to achieve a higher "value of care." As value-maximization efforts expand to include more complex surgical patients, evidence to support meaningful implementation of complication-based initiatives is lacking. The objective of this study was to compare incremental costs of complications following major gastrointestinal (GI) resections for organ-specific malignant neoplasia using nationally representative data. METHODS: National (Nationwide) Inpatient Sample data, 2001-2014, were queried for adult (≥ 18 years) patients undergoing major resections for malignant neoplasia. Based on system-based complications considered relevant to the long-term treatment of GI disease, stratified differences in risk-adjusted incremental hospital costs and complication probabilities were compared. Differences in surgical outcomes and costs over time were also assessed. RESULTS: A total of 293,967 patients were included, weighted to represent 1,408,117 patients nationwide. One fourth (26.1%; 95% CI, 25.7-26.4%) experienced ≥ 1 pre-discharge complication (range, 45.3% esophagectomy to 24.0% rectal resection). Resultant annual risk-adjusted incremental hospital costs totaled $540 million nationwide (19.5% of the overall cost of care and an average of $20,900 per patient). Costs varied substantially with both cancer/resection type and complication group, ranging from $76.7 million for colectomies with infectious complications to $0.2 million for rectal resections with urinary complications. For each resection type, infectious ($154.7 million), GI ($85.5 million), and pulmonary ($77.9 million) complications were among the most significant drivers of increased hospital cost. CONCLUSIONS: Quantifying and comparing the impact of complications on an indication-specific level in more complex patients offers an important step toward allowing providers/payers to meaningfully prioritize the design of novel and adaptation of existing value-maximization approaches.
Entities:
Keywords:
Cancer; Complication; Cost; Infection; Oncology; Quality; Value
Authors: Faiz Gani; Marcelo Cerullo; Joseph K Canner; Alison Conca-Cheng; Alan E Harzman; Syed G Husain; William C Cirocco; Mark W Arnold; Amber Traugott; Fabian M Johnston; Timothy M Pawlik Journal: J Surg Res Date: 2017-08-12 Impact factor: 2.192
Authors: J Hunter Mehaffey; Robert B Hawkins; Matthew G Mullen; Max O Meneveau; Bruce Schirmer; Irving L Kron; R Scott Jones; Peter T Hallowell Journal: J Am Coll Surg Date: 2016-12-23 Impact factor: 6.113
Authors: Sue J Fu; Vanessa P Ho; Jennifer Ginsberg; Yaron Perry; Conor P Delaney; Philip A Linden; Christopher W Towe Journal: Minim Invasive Surg Date: 2016-12-08
Authors: José Eduardo de Aguilar-Nascimento; Alberto Bicudo-Salomão; Mara Regina Rosa Ribeiro; Diana Borges Dock-Nascimento; Cervantes Caporossi Journal: Arq Bras Cir Dig Date: 2022-06-24
Authors: Mauro Podda; Patricia Sylla; Gianluca Baiocchi; Michel Adamina; Vanni Agnoletti; Ferdinando Agresta; Luca Ansaloni; Alberto Arezzo; Nicola Avenia; Walter Biffl; Antonio Biondi; Simona Bui; Fabio C Campanile; Paolo Carcoforo; Claudia Commisso; Antonio Crucitti; Nicola De'Angelis; Gian Luigi De'Angelis; Massimo De Filippo; Belinda De Simone; Salomone Di Saverio; Giorgio Ercolani; Gustavo P Fraga; Francesco Gabrielli; Federica Gaiani; Mario Guerrieri; Angelo Guttadauro; Yoram Kluger; Ari K Leppaniemi; Andrea Loffredo; Tiziana Meschi; Ernest E Moore; Monica Ortenzi; Francesco Pata; Dario Parini; Adolfo Pisanu; Gilberto Poggioli; Andrea Polistena; Alessandro Puzziello; Fabio Rondelli; Massimo Sartelli; Neil Smart; Michael E Sugrue; Patricia Tejedor; Marco Vacante; Federico Coccolini; Justin Davies; Fausto Catena Journal: World J Emerg Surg Date: 2021-07-02 Impact factor: 5.469
Authors: Maleck Louis; Samuel A Johnston; Leonid Churilov; Ronald Ma; Christopher Christophi; Laurence Weinberg Journal: Medicine (Baltimore) Date: 2021-07-09 Impact factor: 1.817